FDA FY 1990
FDA FY 1990 budget: House/Senate conferees tentatively agreed Oct. 5 to a compromise budget providing a total of $ 594.2 mil., including: $ 560.3 mil. for salaries and expenses; $ 8.35 mil. for buildings and facilities and $ 25.6 mil. for rental payments. Compromise also allocates $ 56.9 mil. for AIDS activities. The compromise rejects the Administration's proposal that $ 100 mil. of the FDA budget be derived from "user fees." Report language will include a discussion of the agency's generic drug review program.
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.